Advancing Cancer Treatment
Our Capabilities
Pharsight is the largest drug development modeling and simulation company in the world. Having completed more than 100 projects in 2005 alone, Pharsight Strategic Consulting Services provides expert scientific capabilities to address critical development questions from preclinical testing to post-launch market surveillance. Pharsight resources include seasoned practitioners from industry, government, academia, and consulting. Our multidisciplinary team of more than 20 Ph.D. and MD scientists can optimize your drug development decisions through quantitative exploration of development knowledge and uncertainty that integrates drug/disease models, trial models, and predictive market models.
Leaders in Cancer Drug Development Consulting
Pharsight has world-class expertise in building, integrating and applying drug-disease models to support oncology drug development:
- Population PK
- Tumor growth
- Drug action
- Disease progression
- Toxicity
- Survival
Pharsight has supported a range of oncology development programs and modeling initiatives for industry clients, from pre-clinical to Phase III and covering critical issues in trial design, dose selection, and development strategy. Our recent experience includes exposure-response modeling, allometic projections, and work with novel mechanisms. Pharsight scientists have taken a leadership role at industry conferences, have published in academic journals, and have other publications in progress.